Stay updated on Nivolumab for Recurrent Meningioma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent Meningioma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page version was updated from v3.5.3 to v3.5.4, indicating a minor metadata update rather than substantive changes to the study information.
    Difference
    0.0%
    Check dated 2026-05-15T15:20:00.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page’s displayed system revision/version has been incremented from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T05:43:25.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:28:41.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Updated internal site revision from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T04:44:25.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and v3.4.2 was removed. No substantive changes to the study information or documents are visible.
    Difference
    0.0%
    Check dated 2026-03-11T23:46:44.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    A new site revision note (v3.4.2) was added and older notices/revisions (including a government funding status notice and revision v3.4.1) were removed. There is no impact on the study content or the information presented about the trial.
    Difference
    0.4%
    Check dated 2026-02-11T14:20:58.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Meningioma Clinical Trial page.